(Q42831163)

8 November 2017

title

Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis (English)

1 reference

8 November 2017

1 reference

Mark W Nachtigal

2

0 references

author name string

Diane C Lagace

series ordinal

1

1 reference

8 November 2017

language of work or name

English

0 references

publication date

24 February 2004

1 reference

Journal of Biological Chemistry

8 November 2017

published in

1 reference

8 November 2017

volume

279

1 reference

8 November 2017

issue

18

1 reference

8 November 2017

page(s)

18851-18860

1 reference

Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

A common mechanism of action for three mood-stabilizing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Bodyweight gain and anticonvulsants: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Body weight changes associated with psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Valproic acid fails to induce polycystic ovary syndrome in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Endocrine and metabolic responses to long-term monotherapy with the antiepileptic drug valproate in the normally cycling rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Identification of novel isoform-selective inhibitors within class I histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Adipogenesis and fat-cell function in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Molecular regulation of adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Valproate robustly enhances AP-1 mediated gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Sodium valproate, an anticonvulsant drug, stimulates human cytomegalovirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Proteolytic activation of SREBPs during adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Modulation of the murine peroxisome proliferator-activated receptor gamma 2 promoter activity by CCAAT/enhancer-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Combinatorial roles of the nuclear receptor corepressor in transcription and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

Inhibition of adipogenesis by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312795200

21 January 2018

Identifiers

DOI

10.1074/JBC.M312795200

1 reference

release_gixemn4kjvgxlbim7tptakwn5m

8 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gixemn4kjvgxlbim7tptakwn5m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference